Eris Lifesciences (NSE:ERIS) Total Stockholders Equity : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences Total Stockholders Equity?

Eris Lifesciences's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₹0 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Eris Lifesciences's Book Value per Share for the quarter that ended in Dec. 2023 was ₹N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Eris Lifesciences's Debt-to-Equity for the quarter that ended in Dec. 2023 was .

Eris Lifesciences Total Stockholders Equity Historical Data

The historical data trend for Eris Lifesciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eris Lifesciences Total Stockholders Equity Chart

Eris Lifesciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Stockholders Equity

Get a 7-Day Free Trial

11,505.18

12,963.34

15,764.21

19,083.11

21,959.88

Eris Lifesciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															-	21,959.88	-	24,115.68	-

Eris Lifesciences (NSE:ERIS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Eris Lifesciences's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(0	-	0)	/	136.028
	=	N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Eris Lifesciences's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0
	=

Eris Lifesciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Eris Lifesciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Eris Lifesciences (NSE:ERIS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (NSE:ERIS) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

540596:India

Address

Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054

Website

https://www.eris.co.in

Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences (NSE:ERIS) Headlines

No Headlines